EdgeRock Capital’s CVS Health CVS Stock Holding History

EdgeRock Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-228	Closed	-$22K	–	126
2022 Q3	$22K	Buy	+228	New	+$22.6K	0.01%	156

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EdgeRock Capital's CVS Position: Q4 2022 in Review

EdgeRock Capital sold out of CVS Health (CVS) in Q4 2022, closing a stake of 228 shares — an estimated $22K sold.

EdgeRock Capital first reported a position in CVS in Q3 2022 and held it in 1 quarter. The position peaked at $22K in Q3 2022. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

EdgeRock Capital reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
EdgeRock Capital sold 228 CVS Health shares in Q4 2022, an estimated $22K.
EdgeRock Capital first reported a position in CVS Health in Q3 2022 and held it in 1 quarter.
EdgeRock Capital's CVS Health position peaked at $22K in Q3 2022.
2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on EdgeRock Capital's 13F filing for Q4 2022, filed 14 Feb 2023.